Blau Syndrome
Description
Blau syndrome (BS) is a rare systemic inflammatory disease characterized by early onset granulomatous arthritis, uveitis and skin rash. BS now refers to both the familial and sporadic (formerly early-onset sarcoidosis) form of the same disease. The proposed term pediatric granulomatous arthritis is currently questioned since it fails to represent the systemic nature of the disease.
Clinical Features
Top most frequent phenotypes and symptoms related to Blau Syndrome
- Cataract
- Anemia
- Hypertension
- Fever
- Splenomegaly
- Visual loss
- Glaucoma
- Dyspnea
- Arthralgia
- Photophobia
And another 35 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Researches and researchers
Doctors, researchs, and experts related to Blau Syndrome extracted from public data.
Blau Syndrome Experts map
Current Researchs and researchers
-
BRON — Pr Yves PACHECO
Investigator of research project
-
Institution/s:
— CHU de Lyon HCL - GH Est-Hôpital Louis Pradel -
Research area/topic::
Genetic transmission of familial forms of sarcoidosis
-
Institution/s:
-
LYON — Pr Alain CALENDER
Responsible for diagnostic tests - Investigator of research project - Manager of registry - Coordinator of research network - Director of laboratory
-
Institution/s:
— CHU de Lyon HCL - GH Edouard Herriot -
Research area/topic::
Genetic transmission of familial forms of sarcoidosis
-
Institution/s:
-
MONTPELLIER — Pr Isabelle TOUITOU
Coordinator of expert centre - Clinical expert - Responsible for diagnostic tests - Investigator of research project - Manager of registry - Coordinator of research network - Director of laboratory
-
Institution/s:
— Département Génétique Médicale, Maladies rares et médecine personnalisée, CHRU de Montpellier - Hôpital Arnaud de Villeneuve
— Institut de Médecine Régénérative et Biothérapies, CHU de Montpellier - Hôpital Saint-Eloi -
Research area/topic::
International society of systemic autoinflammatory disorders
-
Institution/s:
Blau Syndrome Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Blau Syndrome (NOD2/CARD15 Complete Gene).
By Center for Genetics at Saint Francis Saint Francis Hospital (United States).
NOD2
Specificity
100 %
Genes
100 % |
Crohn's Disease - NOD2/CARD15 Complete Gene Analysis.
By Center for Genetics at Saint Francis Saint Francis Hospital (United States).
NOD2
Specificity
100 %
Genes
100 % |
NOD2 Deletion/duplication analysis.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
NOD2
Specificity
100 %
Genes
100 % |
NOD2 Sequencing.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
NOD2
Specificity
100 %
Genes
100 % |
NOD2.
By Institute for Human Genetics University Clinic Freiburg (Germany).
NOD2
Specificity
100 %
Genes
100 % |
NOD2. Complete sequencing.
By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
NOD2
Specificity
100 %
Genes
100 % |
NOD2. Sequencing of the exons 5, 8 and 11.
By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
NOD2
Specificity
100 %
Genes
100 % |
Sarcoidosis, early-onset (sequence analysis of NOD2 gene).
By CGC Genetics (Portugal).
NOD2
Specificity
100 %
Genes
100 % |
You can get up to 39 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like STEATOCYSTOMA MULTIPLEX ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY; PEBEL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL4 MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13